Tag: Fresenius Kabi
Caplin Point Laboratories subsidiary gets FDA final approval for Thiamine Hydrochloride Injection
Caplin Point Laboratories said that its subsidiary Caplin Steriles has secured final approval for its abbreviated new drug application (ANDA) for Thiamine Hydrochloride Injection USP, ... Read More
Zydus Lifesciences gets FDA tentative approval for Levothyroxine Sodium generic
Zydus Lifesciences (previously Cadila Healthcare), through its US subsidiary Zydus Pharmaceuticals (USA), has secured tentative approval for Levothyroxine Sodium for injection, 100 mcg/vial, 200 mcg/vial, ... Read More
Fresenius Kabi launches Levothyroxine Sodium Injection Solution in US
German pharma company Fresenius Kabi has launched its severe hypothyroidism treatment -Levothyroxine Sodium Injection Solution in 100 mcg per 5 mL, 200 mcg per 5 ... Read More
Fresenius Kabi launches Omegaven in US for pediatric patients with PNAC
Fresenius Kabi has launched Omegaven (fish oil triglycerides) injectable emulsion in the US, which helps pediatric patients suffering from parenteral nutrition-associated cholestasis (PNAC) with calories ... Read More
Fresenius Kabi launches leukemia drug Trisenox generic in US
German health care company Fresenius Kabi has announced the US launch of Arsenic Trioxide Injection - a generic version of Teva Pharmaceutical Industries’ leukemia drug ... Read More